SCHEMBL2451263

SCHEMBL2451263

NN(C=O)c1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6590409 0.75
SCHEMBL2220312 0.71
Hydrochloric Acid SCHEMBL10702462 0.70
SCHEMBL27667340 0.69 ALDH1A1 (0.39)
SCHEMBL27600811 0.69 ALDH1A1 (0.39)
SCHEMBL28440707 0.68 ALDH1A1 (0.47)
SCHEMBL9662778 0.67 ALDH1A1 (0.35)
SCHEMBL2226558 0.67
SCHEMBL11482412 0.67 ALDH1A1 (0.41)
SCHEMBL4803761 0.66 TRPM8 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104829608-B A kind of cumarin thiazole indolone type compound and its preparation method and purposes 吉首大学 2017-06-30 CN claimed
CN-104817552-B (E) (base of cumarin 3) the hydrazide kind compound preparation method of thiazole 2 of N ' aryl methylenes 4 and purposes 吉首大学 2017-06-27 CN claimed
US-8013153-B2 Substituted pyrimidine kinase inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2011-09-06 US claimed
US-20070254896-A1 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-01 US claimed
WO-2007109783-A2 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-09-27 WO claimed
CN-109265443-A Heterocyclic compound and its application as ASK inhibitor 南京圣和药业股份有限公司 2019-01-25 CN disclosed
CN-104736535-B Heterocyclic modulators of HIF activity for treatment of disease 德州大学系统董事会 2017-12-19 CN disclosed
EP-2844660-B1 TRIAZOLOPYRIDAZINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF SOUTHERN RES INST (US) 2017-11-01 EP disclosed
CN-107266433-A sGC stimulators 铁木医药有限公司 2017-10-20 CN disclosed
CN-104829608-B A kind of cumarin thiazole indolone type compound and its preparation method and purposes 吉首大学 2017-06-30 CN disclosed
CN-104817552-B (E) (base of cumarin 3) the hydrazide kind compound preparation method of thiazole 2 of N ' aryl methylenes 4 and purposes 吉首大学 2017-06-27 CN disclosed
CN-103402515-B sGC stimulators 铁木医药有限公司 2017-05-17 CN disclosed
CN-105980382-A Inhibitors of apoptosis signal-regulating kinases 吉利德科学公司 2016-09-28 CN disclosed
EP-2844660-A1 TRIAZOLOPYRIDAZINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF Southern Research Institute (US) 2015-03-11 EP disclosed
CN-103402515-A Sgc stimulators IRONWOOD PHARMACEUTICALS INC 2013-11-20 CN disclosed
WO-2013166276-A1 TRIAZOLOPYRIDAZINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF SOUTHERN RESEARCH INSTITUTE (US) 2013-11-07 WO disclosed
US-8013153-B2 Substituted pyrimidine kinase inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2011-09-06 US disclosed
US-20070254896-A1 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-01 US disclosed
WO-2007109783-A2 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-09-27 WO disclosed